調査レポートカテゴリー： MarketsandMarkets, 世界

Empty Capsules Market by Type ((Gelatin - Porcine, Bovine, Bone Meal), (HPMC, Pullulan)), Functionality (Sustained-release, Delayed-release), Application (Antibiotics, Vitamins, Antacids), End User (Pharma, Nutraceuticals, Cosmetics) - Forecast to 2023

空カプセルの世界市場予測（～2023年）：ゼラチン、非ゼラチン

◆タイトル：Empty Capsules Market by Type ((Gelatin - Porcine, Bovine, Bone Meal), (HPMC, Pullulan)), Functionality (Sustained-release, Delayed-release), Application (Antibiotics, Vitamins, Antacids), End User (Pharma, Nutraceuticals, Cosmetics) - Forecast to 2023
◆商品コード：PH-2935
◆調査・発行会社：MarketsandMarkets
◆発行日：2018年10月23日
◆ページ数：207
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名利用）USD5,650 ⇒換算￥621,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥896,500見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

 【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、空カプセルの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、タイプ別（ゼラチン、非ゼラチン）分析、機能別（徐放性、遅延放出性）分析、用途別（抗生物質、ビタミン、制酸剤）分析、エンドユーザー別（医薬品、栄養補助食品、化粧品）分析、空カプセルの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“The Global Empty Capsules Market is Projected to Grow at a CAGR of 7.4% from 2018 to 2023.”The empty capsules market is projected to reach USD 2.79 billion by 2023 from an estimated USD 1.95 billion in 2018, at a CAGR of 7.4%. The growing adoption of capsule formulations among the growing geriatric population, the growth of the pharmaceutical market along with the increasing R&D activities & clinical trials, and advancements in capsule delivery technologies are the major factors driving the market for empty capsules. Emerging markets (due to their low manufacturing costs) are expected to present significant opportunities for players. Other areas of opportunity are the development of halal gelatin capsules and the rising focus on sports nutrition. However, cultural practices and dietary restrictions are expected to restrain the growth of the empty capsules market.

“The Non-gelatin Capsules Segment to Register the Highest CAGR During the Forecast Period.”
By type, the empty capsules market is segmented into gelatin and non-gelatin capsules. The gelatin capsules segment is further subsegmented into pig meat gelatin, bovine-derived gelatin, bone meal, and other gelatin sources. The non-gelatin capsules segment is further divided into hydroxypropyl methylcellulose (HPMC) and pullulan & starch material.
The non-gelatin capsules segment is expected to register the highest CAGR during the forecast period. This growth is largely driven by the increasing demand for non-animal-based products and the advantages offered by these capsules over gelatin-based ones, such as low hygroscopicity, physical stability, stability in different ranges of temperature & humidity, and low moisture content.

“Immediate-release Capsules Are Projected to Register the Highest Growth Rate Between 2018 & 2023.”
By functionality, the empty capsules market is segmented into immediate-release, sustained-release, and delayed-release capsules. The immediate-release capsules segment is expected to witness the highest CAGR in the empty capsules market during the forecast period, owing to the widespread use of these capsules for the manufacture of antibiotics, antibacterials, antacids, painkillers, inhalators, cold and cough drug preparations, and dietary supplements. Moreover, these capsules are the most commonly prescribed capsules to treat a wide range of diseases and disorders.

“Dietary Supplements to Witness the Highest Growth Rate in the Forecast Period.”
By application, the empty capsules market is segmented into antibiotic & antibacterial drugs, dietary supplements, antacid & antiflatulent preparations, antianemic preparations, anti-inflammatory drugs, cardiovascular therapy drugs, cough & cold drugs, and other applications. The dietary supplements segment is expected to witness the highest CAGR during the forecast period. Factors such as increased health awareness and rising affordability in emerging countries (such as India, China, and Brazil), increasing prevalence of lifestyle diseases, and increasing use of vitamin capsules due to their availability as over-the-counter (OTC) drugs are contributing to the growth of this segment.

“Nutraceutical Industry to Be the Fastest-growing End-user Segment During the Forecast Period.”
Based on end user, the empty capsules market is segmented into the pharmaceutical industry, nutraceutical industry, cosmetic industry, and research laboratories. The nutraceutical industry segment is expected to witness the highest CAGR during the forecast period. The rising demand for nutraceutical products to prevent the occurrence of lifestyle-associated diseases (such as obesity, arthritis, high blood pressure, cholesterol, and diabetes) is supporting the growth of this segment.

“APAC to Witness the Highest Growth in the Empty Capsules Market During the Forecast Period.”
The empty capsules market in the APAC is expected to witness the highest CAGR during the forecast period. The presence of many global capsule manufacturers in China and India, growth in the pharmaceutical and nutraceutical industries, the relatively less stringent regulations in the nutraceutical industry in this region, an increasing focus on generics, and rising healthcare awareness are expected to drive the adoption of empty capsules in the Asia Pacific.

Break of primary participants was as mentioned below:
• By Company Type: Tier 1: 48%, Tier 2: 34%, and Tier 3: 18%
• By Designation: C-level: 42%, Director-level: 40%, and Others: 18%
• By Region: North America: 38%, Europe: 25%, Asia Pacific: 30%, Latin America: 5%, and the Middle East & Africa: 2%

The prominent players in the global empty capsules market are Capsugel (US), ACG Worldwide (India), Qualicaps (Japan), Suheung Co. Ltd. (South Korea), CapsCanada Corporation (Canada), Qingdao Yiqing Medicinal Capsules Co., Ltd. (China), Shanxi Guangsheng Medicinal Capsules Co., Ltd. (China), Healthcaps India Ltd. (India), Snail Pharma Industry Co. Ltd. (China), Roxlor (US), Sunil Healthcare Ltd. (India), Medi-Caps Ltd. (India), Nectar Lifesciences Ltd. (India), Natural Capsules Ltd. (India), and Bright Pharma Caps Inc. (US).

Research Coverage
The report analyzes the various empty capsule products and their adoption pattern. It aims at estimating the market size and future growth potential of the global empty capsules market for different segments—type, functionality, application, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, and recent developments.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies for strengthening their presence in the market.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global empty capsules market
• Product Development/Innovation: Detailed insights on upcoming trends, R&D activities, and product launches in the global empty capsules market
• Market Development: Comprehensive information on the lucrative and emerging markets
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global empty capsules market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the global empty capsules market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE 17
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 19
1.4 CURRENCY 19
1.5 STAKEHOLDERS 19
1.6 LIMITATIONS 20
2 RESEARCH METHODOLOGY 21
2.1 RESEARCH APPROACH 21
2.1.1 SECONDARY RESEARCH 22
2.1.1.1 Key data from secondary sources 22
2.1.2 PRIMARY RESEARCH 23
2.1.2.1 Key data from primary sources 23
2.1.2.2 Break down of primaries 24
2.1.2.3 Key industry insights 25
2.2 MARKET SIZE ESTIMATION 25
2.3 DATA TRIANGULATION APPROACH 28
2.4 MARKET SHARE ESTIMATION 29
2.5 ASSUMPTIONS FOR THE STUDY 29
3 EXECUTIVE SUMMARY 30
4 PREMIUM INSIGHTS 35
4.1 EMPTY CAPSULES: MARKET OVERVIEW 35
4.2 EMPTY CAPSULES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 36
4.3 REGIONAL MIX: EMPTY CAPSULES MARKET (2018–2023) 37
4.4 EMPTY CAPSULES MARKET: DEVELOPED VS. DEVELOPING MARKETS, 2018 VS. 2023 38
5 MARKET OVERVIEW 39
5.1 INTRODUCTION 39
5.2 MARKET DYNAMICS 39
5.2.1 MARKET DRIVERS 40
5.2.1.1 Growing geriatric population 40
5.2.1.2 Growth of the pharmaceutical market, along with increasing R&D activities and clinical trials 41
5.2.1.3 Advancements in capsule delivery technologies 42
5.2.2 MARKET RESTRAINTS 43
5.2.2.1 Cultural practices and dietary restrictions 43
5.2.3 MARKET OPPORTUNITIES 44
5.2.3.1 Emerging countries 44
5.2.3.2 Development of halal gelatin capsules 45
5.2.3.3 Rising focus on sports nutrition 45
5.2.4 MARKET CHALLENGES 46
5.2.4.1 Rising prices and lower availability of raw materials in the gelatin industry 46
6 INDUSTRY INSIGHTS 47
6.1 INTRODUCTION 47
6.2 INDUSTRY TRENDS 48
6.2.1 RISING DEMAND FOR EMPTY CAPSULES IN THE NUTRACEUTICAL & COSMETIC INDUSTRIES 48
6.2.2 GROWING DEMAND & ADOPTION OF VEGETARIAN CAPSULES 49
6.2.3 INCREASING COLLABORATIONS AMONG EMPTY CAPSULE MANUFACTURERS 49
6.3 PHARMACEUTICAL GELATIN MARKET 50
6.4 PRICING ANALYSIS 51
6.5 REGULATORY ANALYSIS 52
7 EMPTY CAPSULES MARKET, BY TYPE 55
7.1 INTRODUCTION 56
7.2 GELATIN CAPSULES 57
7.2.1 PIG MEAT GELATIN 60
7.2.2 BOVINE-DERIVED GELATIN 61
7.2.3 BONE MEAL 63
7.2.4 OTHER GELATIN SOURCES 64
7.3 NON-GELATIN CAPSULES 65
7.3.1 HYDROXYPROPYL METHYLCELLULOSE (HPMC) 68
7.3.2 PULLULAN & STARCH MATERIAL 70
8 EMPTY CAPSULES MARKET, BY FUNCTIONALITY 72
8.1 INTRODUCTION 73
8.2 IMMEDIATE-RELEASE CAPSULES 74
8.3 SUSTAINED-RELEASE CAPSULES 75
8.4 DELAYED-RELEASE CAPSULES 77
 
9 EMPTY CAPSULES MARKET, BY APPLICATION 79
9.1 INTRODUCTION 80
9.2 ANTIBIOTIC & ANTIBACTERIAL DRUGS 81
9.3 DIETARY SUPPLEMENTS 82
9.4 ANTACID & ANTIFLATULENT PREPARATIONS 84
9.5 ANTIANEMIC PREPARATIONS 85
9.6 ANTI-INFLAMMATORY DRUGS 86
9.7 CARDIOVASCULAR THERAPY DRUGS 87
9.8 COUGH & COLD DRUGS 89
9.9 OTHER APPLICATIONS 90
10 EMPTY CAPSULES MARKET, BY END USER 91
10.1 INTRODUCTION 92
10.2 PHARMACEUTICAL INDUSTRY 93
10.3 NUTRACEUTICAL INDUSTRY 95
10.4 COSMETIC INDUSTRY 96
10.5 RESEARCH LABORATORIES 98
11 EMPTY CAPSULES MARKET, BY REGION 99
11.1 INTRODUCTION 100
11.2 NORTH AMERICA 101
11.2.1 US 107
11.2.2 CANADA 110
11.3 EUROPE 114
11.3.1 GERMANY 119
11.3.2 FRANCE 122
11.3.3 UK 125
11.3.4 ITALY 128
11.3.5 SPAIN 131
11.3.6 REST OF EUROPE 134
11.4 ASIA PACIFIC 137
11.4.1 JAPAN 142
11.4.2 CHINA 145
11.4.3 INDIA 148
11.4.4 REST OF ASIA PACIFIC 152
11.5 LATIN AMERICA 155
11.6 MIDDLE EAST & AFRICA 158
 
12 COMPETITIVE LANDSCAPE 161
12.1 OVERVIEW 161
12.2 MARKET SHARE ANALYSIS 162
12.3 COMPETITIVE SITUATION AND TRENDS 164
12.3.1 PRODUCT LAUNCHES 164
12.3.2 EXPANSIONS 165
12.3.3 ACQUISITIONS 166
12.3.4 OTHER STRATEGIES 167
13 COMPANY PROFILES 168
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
13.1 CAPSUGEL 168
13.2 ACG WORLDWIDE 173
13.3 QUALICAPS 176
13.4 SUHEUNG CO., LTD. 179
13.5 CAPSCANADA CORPORATION 181
13.6 QINGDAO YIQING MEDICINAL CAPSULES CO., LTD. 183
13.7 SHANXI GUANGSHENG MEDICINAL CAPSULES CO., LTD. 184
13.8 HEALTHCAPS INDIA LTD. 185
13.9 SNAIL PHARMA INDUSTRY CO. LTD. 186
13.10 ROXLOR 187
13.11 SUNIL HEALTHCARE LTD. 188
13.12 MEDI-CAPS LTD. 190
13.13 NECTAR LIFESCIENCES LTD. 192
13.14 NATURAL CAPSULES LIMITED 194
13.15 BRIGHT PHARMA CAPS INC. 196
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
14 APPENDIX 197
14.1 INSIGHTS OF INDUSTRY EXPERTS 197
14.2 DISCUSSION GUIDE 198
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 203
14.4 AVAILABLE CUSTOMIZATIONS 205
14.5 RELATED REPORTS 205
14.6 AUTHOR DETAILS 206

LIST OF TABLES

TABLE 1 KEY MARKET DRIVERS: IMPACT ANALYSIS 43
TABLE 2 KEY MARKET RESTRAINTS: IMPACT ANALYSIS 43
TABLE 3 KEY MARKET OPPORTUNITIES: IMPACT ANALYSIS 45
TABLE 4 KEY MARKET CHALLENGES: IMPACT ANALYSIS 46
TABLE 5 AVERAGE PRICE OF EMPTY CAPSULES, BY REGION, 2017 51
TABLE 6 DIMENSIONAL SPECIFICATION PARAMETERS 52
TABLE 7 EMPTY CAPSULES MARKET, BY TYPE, 2016–2023 (USD MILLION) 56
TABLE 8 EMPTY CAPSULES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 57
TABLE 9 GELATIN CAPSULES MARKET, BY RAW MATERIAL, 2016–2023 (USD MILLION) 59
TABLE 10 GELATIN CAPSULES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 59
TABLE 11 GELATIN CAPSULES MARKET, BY REGION, 2016–2023 (BILLION UNITS) 60
TABLE 12 PIG MEAT GELATIN MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 61
TABLE 13 BOVINE-DERIVED GELATIN MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 62
TABLE 14 BONE MEAL MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 63
TABLE 15 OTHER GELATIN SOURCES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 64
TABLE 16 NON-GELATIN CAPSULES MARKET, BY RAW MATERIAL, 2016–2023 (USD MILLION) 66
TABLE 17 NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 67
TABLE 18 NON-GELATIN CAPSULES MARKET, BY REGION, 2016–2023 (BILLION UNITS) 67
TABLE 19 MAJOR PRODUCTS IN THE MARKET 68
TABLE 20 HYDROXYPROPYL METHYL CELLULOSE (HPMC) MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 69
TABLE 21 PULLULAN & STARCH MATERIAL MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 71
TABLE 22 EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2016–2023 (USD MILLION) 73
TABLE 23 IMMEDIATE-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 75
TABLE 24 SUSTAINED-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 76
TABLE 25 DELAYED-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 78
TABLE 26 EMPTY CAPSULES MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 81
TABLE 27 EMPTY CAPSULES MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS,
BY COUNTRY, 2016–2023 (USD MILLION) 82
TABLE 28 EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY,
2016–2023 (USD MILLION) 83
TABLE 29 EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS,
BY COUNTRY, 2016–2023 (USD MILLION) 84
TABLE 30 EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2016–2023 (USD MILLION) 85
TABLE 31 EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2016–2023 (USD MILLION) 87
TABLE 32 EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS,
BY COUNTRY, 2016–2023 (USD MILLION) 88
TABLE 33 EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS, BY COUNTRY,
2016–2023 (USD MILLION) 89
TABLE 34 EMPTY CAPSULES MARKET FOR OTHER APPLICATIONS, BY COUNTRY,
2016–2023 (USD MILLION) 90
TABLE 35 EMPTY CAPSULES MARKET, BY END USER, 2016–2023 (USD MILLION) 92
TABLE 36 EMPTY CAPSULES MARKET FOR THE PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2016–2023 (USD MILLION) 94
TABLE 37 EMPTY CAPSULES MARKET FOR THE NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2016–2023 (USD MILLION) 96
TABLE 38 EMPTY CAPSULES MARKET FOR THE COSMETIC INDUSTRY, BY COUNTRY,
2016–2023 (USD MILLION) 97
TABLE 39 EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY,
2016–2023 (USD MILLION) 98
TABLE 40 EMPTY CAPSULES MARKET, BY REGION, 2016–2023 (USD MILLION) 101
TABLE 41 EMPTY CAPSULES MARKET, BY REGION, 2016–2023 (BILLION UNITS) 101
TABLE 42 NORTH AMERICA: EMPTY CAPSULES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 104
TABLE 43 NORTH AMERICA: EMPTY CAPSULES MARKET, BY TYPE,
2016–2023 (USD MILLION) 104
TABLE 44 NORTH AMERICA: GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 104
TABLE 45 NORTH AMERICA: NON-GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 105
TABLE 46 NORTH AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,
2016–2023 (USD MILLION) 105
TABLE 47 NORTH AMERICA: EMPTY CAPSULES MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 106
TABLE 48 NORTH AMERICA: EMPTY CAPSULES MARKET, BY END USER,
2016–2023 (USD MILLION) 106
TABLE 49 US: EMPTY CAPSULES MARKET, BY TYPE, 2016–2023 (USD MILLION) 108
TABLE 50 US: GELATIN CAPSULES MARKET, BY RAW MATERIAL, 2016–2023 (USD MILLION) 108
TABLE 51 US: NON-GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 108
TABLE 52 US: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2016–2023 (USD MILLION) 109
TABLE 53 US: EMPTY CAPSULES MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 109
TABLE 54 US: EMPTY CAPSULES MARKET, BY END USER, 2016–2023 (USD MILLION) 110
TABLE 55 CANADA: EMPTY CAPSULES MARKET, BY TYPE, 2016–2023 (USD MILLION) 111
TABLE 56 CANADA: GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 111
TABLE 57 CANADA: NON-GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 112
TABLE 58 CANADA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,
2016–2023 (USD MILLION) 112
TABLE 59 CANADA: EMPTY CAPSULES MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 113
TABLE 60 CANADA: EMPTY CAPSULES MARKET, BY END USER, 2016–2023 (USD MILLION) 113
TABLE 61 EUROPE: EMPTY CAPSULES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 116
TABLE 62 EUROPE: EMPTY CAPSULES MARKET, BY TYPE, 2016–2023 (USD MILLION) 116
TABLE 63 EUROPE: GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 116
TABLE 64 EUROPE: NON-GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 117
TABLE 65 EUROPE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,
2016–2023 (USD MILLION) 117
TABLE 66 EUROPE: EMPTY CAPSULES MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 118
TABLE 67 EUROPE: EMPTY CAPSULES MARKET, BY END USER, 2016–2023 (USD MILLION) 118
TABLE 68 GERMANY: EMPTY CAPSULES MARKET, BY TYPE, 2016–2023 (USD MILLION) 119
TABLE 69 GERMANY: GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 120
TABLE 70 GERMANY: NON-GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 120
TABLE 71 GERMANY: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,
2016–2023 (USD MILLION) 120
TABLE 72 GERMANY: EMPTY CAPSULES MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 121
TABLE 73 GERMANY: EMPTY CAPSULES MARKET, BY END USER, 2016–2023 (USD MILLION) 121
TABLE 74 FRANCE: EMPTY CAPSULES MARKET, BY TYPE, 2016–2023 (USD MILLION) 122
TABLE 75 FRANCE: GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 123
TABLE 76 FRANCE: NON-GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 123
TABLE 77 FRANCE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,
2016–2023 (USD MILLION) 123
TABLE 78 FRANCE: EMPTY CAPSULES MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 124
TABLE 79 FRANCE: EMPTY CAPSULES MARKET, BY END USER, 2016–2023 (USD MILLION) 124
TABLE 80 UK: EMPTY CAPSULES MARKET, BY TYPE, 2016–2023 (USD MILLION) 125
TABLE 81 UK: GELATIN CAPSULES MARKET, BY RAW MATERIAL, 2016–2023 (USD MILLION) 125
TABLE 82 UK: NON-GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 126
TABLE 83 UK: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2016–2023 (USD MILLION) 126
TABLE 84 UK: EMPTY CAPSULES MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 127
TABLE 85 UK: EMPTY CAPSULES MARKET, BY END USER, 2016–2023 (USD MILLION) 127
TABLE 86 ITALY: EMPTY CAPSULES MARKET, BY TYPE, 2016–2023 (USD MILLION) 128
TABLE 87 ITALY: GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 129
TABLE 88 ITALY: NON-GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 129
TABLE 89 ITALY: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2016–2023 (USD MILLION) 129
TABLE 90 ITALY: EMPTY CAPSULES MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 130
TABLE 91 ITALY: EMPTY CAPSULES MARKET, BY END USER, 2016–2023 (USD MILLION) 130
TABLE 92 SPAIN: EMPTY CAPSULES MARKET, BY TYPE, 2016–2023 (USD MILLION) 131
TABLE 93 SPAIN: GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 131
TABLE 94 SPAIN: NON-GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 132
TABLE 95 SPAIN: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,
2016–2023 (USD MILLION) 132
TABLE 96 SPAIN: EMPTY CAPSULES MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 133
TABLE 97 SPAIN: EMPTY CAPSULES MARKET, BY END USER, 2016–2023 (USD MILLION) 133
TABLE 98 ROE: EMPTY CAPSULES MARKET, BY TYPE, 2016–2023 (USD MILLION) 134
TABLE 99 ROE: GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 135
TABLE 100 ROE: NON-GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 135
TABLE 101 ROE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2016–2023 (USD MILLION) 135
TABLE 102 ROE: EMPTY CAPSULES MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 136
TABLE 103 ROE: EMPTY CAPSULES MARKET, BY END USER, 2016–2023 (USD MILLION) 136
TABLE 104 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 139
TABLE 105 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY TYPE, 2016–2023 (USD MILLION) 139
TABLE 106 ASIA PACIFIC: GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 139
TABLE 107 ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 140
TABLE 108 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,
2016–2023 (USD MILLION) 140
TABLE 109 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 141
TABLE 110 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY END USER,
2016–2023 (USD MILLION) 141
TABLE 111 JAPAN: EMPTY CAPSULES MARKET, BY TYPE, 2016–2023 (USD MILLION) 142
TABLE 112 JAPAN: GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 143
TABLE 113 JAPAN: NON-GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 143
TABLE 114 JAPAN: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,
2016–2023 (USD MILLION) 143
TABLE 115 JAPAN: EMPTY CAPSULES MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 144
TABLE 116 JAPAN: EMPTY CAPSULES MARKET, BY END USER, 2016–2023 (USD MILLION) 144
TABLE 117 CHINA: EMPTY CAPSULES MARKET, BY TYPE, 2016–2023 (USD MILLION) 146
TABLE 118 CHINA: GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 146
TABLE 119 CHINA: NON-GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 146
TABLE 120 CHINA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,
2016–2023 (USD MILLION) 147
TABLE 121 CHINA: EMPTY CAPSULES MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 147
TABLE 122 CHINA: EMPTY CAPSULES MARKET, BY END USER, 2016–2023 (USD MILLION) 148
TABLE 123 INDIA: EMPTY CAPSULES MARKET, BY TYPE, 2016–2023 (USD MILLION) 149
TABLE 124 INDIA: GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 149
TABLE 125 INDIA: NON-GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 150
TABLE 126 INDIA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,
2016–2023 (USD MILLION) 150
TABLE 127 INDIA: EMPTY CAPSULES MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 151
TABLE 128 INDIA: EMPTY CAPSULES MARKET, BY END USER, 2016–2023 (USD MILLION) 151
TABLE 129 ROAPAC: EMPTY CAPSULES MARKET, BY TYPE, 2016–2023 (USD MILLION) 152
TABLE 130 ROAPAC: GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 153
TABLE 131 ROAPAC: NON-GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 153
TABLE 132 ROAPAC: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,
2016–2023 (USD MILLION) 153
TABLE 133 ROAPAC: EMPTY CAPSULES MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 154
TABLE 134 ROAPAC: EMPTY CAPSULES MARKET, BY END USER, 2016–2023 (USD MILLION) 154
TABLE 135 LATIN AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2016–2023 (USD MILLION) 155
TABLE 136 LATIN AMERICA: GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 156
TABLE 137 LATIN AMERICA: NON-GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 156
TABLE 138 LATIN AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,
2016–2023 (USD MILLION) 156
TABLE 139 LATIN AMERICA: EMPTY CAPSULES MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 157
TABLE 140 LATIN AMERICA: EMPTY CAPSULES MARKET, BY END USER,
2016–2023 (USD MILLION) 157
TABLE 141 MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET, BY TYPE,
2016–2023 (USD MILLION) 158
TABLE 142 MIDDLE EAST & AFRICA: GELATIN CAPSULES MARKET, BY RAW MATERIAL,
2016–2023 (USD MILLION) 159
TABLE 143 MIDDLE EAST & AFRICA: NON-GELATIN CAPSULES MARKET, BY RAW MATERIAL, 2016–2023 (USD MILLION) 159
TABLE 144 MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,
2016–2023 (USD MILLION) 159
TABLE 145 MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 160
TABLE 146 MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET, BY END USER,
2016–2023 (USD MILLION) 160
TABLE 147 PRODUCT LAUNCHES, 2015–2018 164
TABLE 148 EXPANSIONS, 2015–2018 165
TABLE 149 ACQUISITIONS, 2015–2018 166
TABLE 150 OTHER STRATEGIES, 2015–2018 167


LIST OF FIGURES

FIGURE 1 EMPTY CAPSULES MARKET 18
FIGURE 2 RESEARCH DESIGN 21
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATIONS, AND REGION 24
FIGURE 4 BOTTOM-UP APPROACH 26
FIGURE 5 TOP-DOWN APPROACH 27
FIGURE 6 DATA TRIANGULATION METHODOLOGY 28
FIGURE 9 EMPTY CAPSULES MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION) 32
FIGURE 12 GROWTH OF THE PHARMACEUTICAL INDUSTRY ALONG WITH R&D ACTIVITIES AND CLINICAL TRIALS TO DRIVE MARKET GROWTH 35
FIGURE 13 US DOMINATED THE EMPTY CAPSULES MARKET IN 2017 36
FIGURE 14 APAC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD (2018–2023) 37
FIGURE 15 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE BETWEEN
2018 & 2023 38
FIGURE 16 EMPTY CAPSULES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 39
FIGURE 17 PROJECTED GROWTH IN THE ELDERLY POPULATION, 2010 VS. 2015 VS. 2030 40
FIGURE 18 TOTAL R&D PIPELINE SIZE (2011–2017) 41
FIGURE 19 GROWTH IN THE NUTRACEUTICAL & COSMETIC INDUSTRIES AND INCREASING COLLABORATIONS AMONG EMPTY CAPSULE MANUFACTURERS ARE THE LEADING TRENDS IN THE MARKET 48
FIGURE 20 GLOBAL GELATIN PRODUCTION, BY REGION (2017) 50
FIGURE 21 GLOBAL GELATIN MARKET, BY END USER (2017) 51
FIGURE 22 GELATIN CAPSULES TO DOMINATE THE EMPTY CAPSULES MARKET DURING THE FORECAST PERIOD 56
FIGURE 23 PIG MEAT GELATIN TO CONTINUE TO DOMINATE THE GELATIN CAPSULES MARKET DURING THE FORECAST PERIOD 58
FIGURE 24 HYDROXYPROPYL METHYLCELLULOSE TO CONTINUE TO ACCOUNT FOR THE LARGEST SHARE OF THE NON-GELATIN CAPSULES MARKET 66
FIGURE 25 IMMEDIATE-RELEASE CAPSULES SEGMENT TO DOMINATE THE EMPTY CAPSULES MARKET DURING THE FORECAST PERIOD 73
FIGURE 26 ANTIBIOTIC & ANTIBACTERIAL DRUGS SEGMENT WILL CONTINUE TO DOMINATE THE EMPTY CAPSULES MARKET IN 2023 80
FIGURE 27 PHARMACEUTICAL INDUSTRY SEGMENT TO DOMINATE THE EMPTY CAPSULES MARKET DURING THE FORECAST PERIOD 93
FIGURE 28 EMPTY CAPSULES MARKET: GEOGRAPHIC SNAPSHOT (2017) 100
FIGURE 29 NORTH AMERICA: EMPTY CAPSULES MARKET SNAPSHOT 103
FIGURE 30 USE OF DIETARY SUPPLEMENTS (2008–2017) 107
FIGURE 31 EUROPEAN GENERICS MARKET (2014) 114
FIGURE 32 EUROPE: EMPTY CAPSULES MARKET SNAPSHOT 115
FIGURE 33 ASIA PACIFIC: EMPTY CAPSULES MARKET SNAPSHOT 138
FIGURE 34 EXPANSIONS—KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS FROM 2015 TO AUGUST 2018 161
FIGURE 35 EMPTY CAPSULES MARKET SHARE, BY KEY PLAYER, 2017 162
FIGURE 36 SUNIL HEALTHCARE LTD.: COMPANY SNAPSHOT 188
FIGURE 37 MEDI-CAPS LTD.: COMPANY SNAPSHOT 190
FIGURE 38 NECTAR LIFESCIENCES: COMPANY SNAPSHOT (2017) 192
FIGURE 39 NATURAL CAPSULES LIMITED: COMPANY SNAPSHOT (2017) 194


★調査レポート[空カプセルの世界市場予測（～2023年）：ゼラチン、非ゼラチン] ( Empty Capsules Market by Type ((Gelatin - Porcine, Bovine, Bone Meal), (HPMC, Pullulan)), Functionality (Sustained-release, Delayed-release), Application (Antibiotics, Vitamins, Antacids), End User (Pharma, Nutraceuticals, Cosmetics) - Forecast to 2023 / PH-2935) 販売に関する免責事項
[空カプセルの世界市場予測（～2023年）：ゼラチン、非ゼラチン] ( Empty Capsules Market by Type ((Gelatin - Porcine, Bovine, Bone Meal), (HPMC, Pullulan)), Functionality (Sustained-release, Delayed-release), Application (Antibiotics, Vitamins, Antacids), End User (Pharma, Nutraceuticals, Cosmetics) - Forecast to 2023 / PH-2935) についてEメールでお問い合わせ
◆関連調査資料◆
  • 止血剤の世界市場予測（～2023年）：トロンビン、酸化再生セルロース、併用止血剤、ゼラチン、コラーゲン
    MD-4093 / MarketsandMarkets / 2018年9月10日 / MarketsandMarketsが発行した当調査レポートでは、止血剤の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品（トロンビン、酸化再生セルロース、併用止血剤、ゼラチン、コラーゲン）分析、用途（婦人科、神経外科、心臓血管、再建）分析、形態（粉体、マトリックス材・ゲル、シート・パッド）分析、止血剤の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global hemostats market is expected to reach USD 3.03 billion by 2023 from USD 2.27 billion in 2018, at a CAGR of 6.0%. Growth in this market is driven by the increasing number of surgical procedures, growing number of regulatory approvals, increasing incidence of sports-related injuries and spinal ailments, and rising focus on effective blood loss management in patients during surgeries. In addition, the emerging markets and growth in the number of hospitals and surgical centers are expected to offer further growth opportunities for players operating in the hemostats market during the forecast period. The global hemostats market is...
  • 医薬品用賦形剤の世界市場予測（～2023年）：種類、機能、構成、地域別分析
    PH-3047 / MarketsandMarkets / 2018年3月22日 / MarketsandMarketsが発行した当調査レポートでは、医薬品用賦形剤の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、種類別分析、機能別分析、構成別分析、地域別分析、医薬品用賦形剤の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global pharmaceutical excipients market is projected to reach USD 8.53 Billion by 2023 from USD 6.40 Billion in 2018, growing at a CAGR of 5.9%. Factors such as the growing demand for pharmaceuticals due to the rising aging population and the incidence of chronic diseases, advancements in functional excipient development, growing generics market due to patent cliffs, rapidly growing biopharmaceuticals sector, emergence of multifunctional & co-processed excipients, and the growing biosimilars industry are driving the market growth. The report analyzes the market by product, functionality, type of formulation, and region. Based on product, the organic chemical excipients segment accounted...
  • 治療薬モニタリングの世界市場予測（～2023年）
    MD-4185 / MarketsandMarkets / 2018年8月22日 / MarketsandMarketsが発行した当調査レポートでは、治療薬モニタリングの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品別（消耗品、装置）分析、技術別（蛍光免疫測定、放射免疫測定法、GCMS）分析、薬剤クラス別（抗生物質、気管支拡張剤）分析、エンドユーザー別（病院内ラボ）分析、治療薬モニタリングの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global therapeutic drug monitoring (TDM) market is projected to reach USD 1.63 billion by 2023 from USD 1.23 billion in 2018, at a CAGR of 5.9% during the forecast period. Market growth is largely driven by factors rising number of organ transplant procedures and the use of TDM in traditional anticancer therapies. In this report, the market has been categorized based on product, class of drugs, technology, end user, and region. On the basis of technology, the therapeutic drug monitoring market is segmented into immunoassay and chromatography & MS. In 2018, the immunoassay segment is expected to account for...
  • 分取・プロセスクロマトグラフィーの世界市場予測（～2023年）
    MAM-AST-3797 / MarketsandMarkets / 2018年10月3日 / MarketsandMarketsが発行した当調査レポートでは、分取・プロセスクロマトグラフィーの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、タイプ別（分取、プロセス）分析、エンドユーザー別（バイオテクノロジー、医薬品）分析、分取・プロセスクロマトグラフィーの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global process and preparative chromatography market size is expected to reach USD 8.60 billion by 2023 from the estimated USD 6.27 billion in 2018, at a CAGR of 6.5%. The major factors driving the growth of this market are increasing R&D investments in biotechnology and pharmaceutical industries and rising demand for monoclonal antibodies, insulin, and other pharmaceutical products. On the basis of type, the process and preparative chromatography market has been segmented into two segments, namely, process chromatography and preparative chromatography. Each segment has been further divided based on products and service. In 2018, the process chromatography segment is...
  • 動物向け疼痛治療の世界市場予測（～2023年）
    MD6197 / MarketsandMarkets / 2018年4月20日 / 当調査レポートでは、動物向け疼痛治療の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品（薬剤、デバイス）別分析、用途別分析、動物種類別分析、販売チャネル別分析、動物向け疼痛治療の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“Global veterinary pain management market projected to grow at a CAGR of 8.0%”The global veterinary pain management market is projected to reach USD 1.66 billion by 2023 from USD 1.13 billion in 2018, at a CAGR of 8.0% during the forecast period. Factors such as growth in companion animal adoption, increasing number of veterinary practitioners and their rising income levels in developed economies, growing prevalence of animal diseases causing pain and inflammation, and rising adoption of pet insurance with growing animal health expenditure are expected to drive the growth of the market. However, increasing pet care cost may restrain market...
  • バイオサージャリーの世界市場予測（～2023年）：フィブリン・コラーゲンシーラント、止血剤、癒着防止バリア、生物学的メッシュ、軟組織着材、ステープラー、代用骨移植片
    MD-3554 / MarketsandMarkets / 2018年7月17日 / MarketsandMarketsが発行した当調査レポートでは、バイオサージャリーの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、製品別（フィブリン・コラーゲンシーラント、止血剤、癒着防止バリア、生物学的メッシュ、軟組織着材、ステープラー、代用骨移植片）分析、用途別（整形外科、婦人科、循環器系科、再建手術）分析、バイオサージャリーの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global biosurgery market is projected to reach USD 15.58 billion by 2023 from USD 11.36 billion in 2018, at a CAGR of 6.5%. The growth of this market is driven by the growing geriatric population and corresponding chronic diseases, increasing volume of surgeries and prevalence of severe trauma injuries, and rising need for effective blood loss management in patients. The market is segmented based on products, applications, and regions. Based on the product type, the bone-graft substitutes segment accounted for the largest share of the market in 2017. The large share of this segment is attributed to the increasing...
  • コラーゲンペプチドの世界市場予測（～2023年）
    FB3198 / MarketsandMarkets / 2018年7月25日 / MarketsandMarketsが発行した当調査レポートでは、コラーゲンペプチドの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、ソース別（牛皮・骨、豚、家禽、魚類）分析、用途別（栄養製品、スナック・穀物、乳製品、飲料、肉・家禽製品）分析、コラーゲンペプチドの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The collagen peptides market is projected to reach USD 1,337.0 million by 2023, from USD 772.3 million in 2018, growing at a CAGR of 11.6%. Wide application of collagen peptides as a functional ingredient in food processing and rising consumer inclination toward healthy lifestyles act as factors driving the collagen peptides market growth. Based on the source, the collagen peptides market has been segmented into cattle hide & bones, pigskin, and poultry & fish. The pigskin segment dominated the market in 2018, and this trend is projected to continue through the forecast period from 2018 to 2023. Different methods are...
  • 超崩壊剤の世界市場予測（～2023年）：加工デンプン、加工セルロース、クロスポビドン、イオン交換樹脂
    PH-4350 / MarketsandMarkets / 2018年8月30日 / MarketsandMarketsが発行した当調査レポートでは、超崩壊剤の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別（加工デンプン、加工セルロース、クロスポビドン、イオン交換樹脂）分析、剤形別（タブレット、カプセル）分析、治療領域別（消化器官、心血管、神経学、腫瘍学、血液学）分析、超崩壊剤の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global superdisintegrants market is projected to reach USD 536.5 million by 2023 from USD 366.4 million in 2018, at a CAGR of 7.9%. Factors contributing to the growth of this market include the increasing adoption of orally disintegrating tablets, growing generics market, and the emergence of new superdisintegrants for the pharmaceutical industry. The shifting focus of pharmaceutical manufacturing to emerging markets and the growth of the overall pharmaceutical sector in these markets present significant opportunities for the superdisintegrants market growth. The report analyzes the global superdisintegrants market by type, formulation, therapeutic area, and region. By type, the synthetic superdisintegrants...
  • 海洋性コラーゲンの世界市場予測（～2023年）
    MAM-FB-6182 / MarketsandMarkets / 2018年4月17日 / MarketsandMarketsが発行した当調査レポートでは、海洋性コラーゲンの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別分析、原料別分析、動物別分析、用途（栄養食品、化粧品、医療）別分析、海洋性コラーゲンの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global market for marine collagen has grown exponentially in the last few years. The market is estimated to be valued at USD 620.3 Million in 2018 and is projected to reach USD 897.5 Million by 2023, growing at a CAGR of 7.7%. Emerging economies such as India, China, and Brazil are the potential primary markets. Factors such as the growing inclination toward healthy lifestyles among consumers and high protein consumption have significantly fueled the demand for marine collagen due to its various health benefits such as regeneration of skin & bones and better bioavailability as compared to other collagen...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆